Awarded contractOpenSuppliesCzech Republic
Imunosupresiva - inhibitory TNF alfa - infliximab II. - i.v. podání
2 suppliers awarded•2 lots awarded•€476,854 awarded
Buyer: Institut klinické a experimentální medicíny / Praha, Czech Republic
Published Jun 26, 2024Awarded May 22, 2024
Immunosuppressive agents
Awarded value
€476.9K
Estimated value
€476.9K
Awarded at 100% of estimated value
Award date
May 22, 2024
Winners
2
Lots awarded
2
Award values
Notice total
€476.9K
Sum of lot awards
€371.6K
TED notice total and lot-level values do not exactly match.
Winners
PROMEDICA PRAHA GROUP, a.s.
1 lotPraha - Bubeneč, CZE
€210,426 This contract
87 award notices•106 awarded lots•€39.37M total
Merck Sharp & Dohme s.r.o.
1 lotPraha - Smíchov, CZE
€161,188 This contract
15 award notices•16 awarded lots•€47.38M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | PROMEDICA PRAHA GROUP, a.s. | €210,426 | Immunosuppressive agents (33652300) | |
| LOT-0002 | Merck Sharp & Dohme s.r.o. | €161,188 | Immunosuppressive agents (33652300) |